Atossa Therapeutics
ATOS
#10603
Rank
S$30.94 M
Marketcap
S$3.10
Share price
1.26%
Change (1 day)
206.24%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -S$48.28 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$44.58 Million a decrease over its 2024 earnings that were of -S$32.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$48.28 Million8.29%
2025 -S$44.58 Million36.33%
2024 -S$32.7 Million-15.25%
2023 -S$38.59 Million11.62%
2022 -S$34.57 Million30.84%
2021 -S$26.42 Million15.58%
2020 -S$22.86 Million3.41%
2019 -S$22.11 Million51.16%
2018 -S$14.63 Million40.41%
2017 -S$10.42 Million27.54%
2016 -S$8.17 Million-47.49%
2015 -S$15.56 Million-17.25%
2014 -S$18.8 Million35.91%
2013 -S$13.83 Million112.3%
2012 -S$6.52 Million46.53%
2011 -S$4.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.30 B-69,117.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$1.76 B-3,755.59%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$1.76 B-3,753.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
S$53.44 M-210.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-S$0.13 Billion 164.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-S$10.06 Million-79.17%๐Ÿ‡บ๐Ÿ‡ธ USA